# Vitamin A ```text DRUG INFORMATION ADULT - Add one daily dose of Vial 1 and one daily dose of Vial 2 directly to at least 100 mL of intravenous dextrose or saline solution prior to intravenous use ( 2.3 ) • Pharmacy Bulk Package consists of two vials labeled Vial 1 and Vial 2. Source: US FDA label for vitamin a (Pediatric Infuvite Multiple Vitamins), section 'dosage and administration', retrieved 2026-08-29 - Then, take 1.5 mL, 3.25 mL, or 5 mL from mixture and add to at least 100 mL of intravenous dextrose or saline solution prior to intravenous use ( 2.3 ) • After dilution in an intravenous infusion, refrigerate resulting solution unless used immediately. Source: US FDA label for vitamin a (Pediatric Infuvite Multiple Vitamins), section 'dosage and administration', retrieved 2026-08-29 - The mixed solution (50 mL) will provide thirty-three 1.5 mL single doses, fifteen 3.25 mL single doses or ten 5 mL single doses. • Each bulk vial closure shall be penetrated only one time with a suitable sterile transfer device or dispensing set that allows measured dispensing of the contents. • Once the closure system has been penetrated, complete dispensing from the pharmacy bulk vial should be completed within 4 hours. Source: US FDA label for vitamin a (Pediatric Infuvite Multiple Vitamins), section 'dosage and administration', retrieved 2026-08-29 CHILD - INFUVITE PEDIATRIC is approved for the prevention of vitamin deficiency in pediatric patients up to 11 years old receiving parenteral nutrition. INFUVITE PEDIATRIC has not been studied in pediatric patients older than 11 years. INFUVITE PEDIATRIC contains aluminum that may be toxic for premature neonates. Source: US FDA label for vitamin a (Pediatric Infuvite Multiple Vitamins), section 'pediatric use', retrieved 2026-08-29 - INFUVITE PEDIATRIC Single Dose (see Table 1): One daily dose of Vial 1 (1.2 mL, 2.6 mL or 4 mL) and one daily dose of Vial 2 (0.3 mL, 0.65 mL or 1 mL) based on the patient’s weight are added directly to a specified volume of an intravenous fluid [ see Dosage and Administration ( 2.3 ) ] (see Table 1). Source: This line points to a numbered table that this card does not show - read that table in the label before you dose. US FDA label for vitamin a (Pediatric Infuvite Multiple Vitamins), section 'dosage and administration', retrieved 2026-08-29 - Add one weight-based dose of Vial 1 (1.2 mL, 2.6 mL or 4 mL) and one weight-based dose of Vial 2 (0.3 mL, 0.65 mL or 1 mL) directly to at least 100 mL of intravenous dextrose or saline solution. • Discard unused portion. • Visually inspect for particulate matter and discoloration prior to administration. Source: US FDA label for vitamin a (Pediatric Infuvite Multiple Vitamins), section 'dosage and administration', retrieved 2026-08-29 RENAL IMPAIRMENT - • Renal Impairment: Monitor renal function, calcium, phosphorus and vitamin A levels ( 8.6 ) • Hepatic Impairment: Monitor vitamin A levels ( 8.7 ) 8.1 Pregnancy Pregnancy Category C. Source: US FDA label for vitamin a (Pediatric Infuvite Multiple Vitamins), section 'use in specific populations', retrieved 2026-08-29 - No E-Ferol syndrome associated with INFUVITE PEDIATRIC has been reported [ see Warnings and Precautions ( 5.10 ) ]. 8.6 Renal Impairment INFUVITE PEDIATRIC has not been studied in patients with renal impairment. Source: US FDA label for vitamin a (Pediatric Infuvite Multiple Vitamins), section 'use in specific populations', retrieved 2026-08-29 - Monitor renal function, calcium, phosphorus and vitamin A levels in patients with renal impairment [ see Warnings and Precautions ( 5.1 , 5.3 ) ] . 8.7 Hepatic Impairment INFUVITE PEDIATRIC has not been studied in patients with liver impairment. Source: US FDA label for vitamin a (Pediatric Infuvite Multiple Vitamins), section 'use in specific populations', retrieved 2026-08-29 HEPATIC IMPAIRMENT - • Renal Impairment: Monitor renal function, calcium, phosphorus and vitamin A levels ( 8.6 ) • Hepatic Impairment: Monitor vitamin A levels ( 8.7 ) 8.1 Pregnancy Pregnancy Category C. Source: US FDA label for vitamin a (Pediatric Infuvite Multiple Vitamins), section 'use in specific populations', retrieved 2026-08-29 - Monitor renal function, calcium, phosphorus and vitamin A levels in patients with renal impairment [ see Warnings and Precautions ( 5.1 , 5.3 ) ] . 8.7 Hepatic Impairment INFUVITE PEDIATRIC has not been studied in patients with liver impairment. Source: US FDA label for vitamin a (Pediatric Infuvite Multiple Vitamins), section 'use in specific populations', retrieved 2026-08-29 - Monitor vitamin A levels in patients with liver disease [ see Warnings and Precautions ( 5.3 ) ] . Source: US FDA label for vitamin a (Pediatric Infuvite Multiple Vitamins), section 'use in specific populations', retrieved 2026-08-29 PREGNANCY - INFUVITE PEDIATRIC has not been studied in pregnant women. Source: US FDA label for vitamin a (Pediatric Infuvite Multiple Vitamins), section 'pregnancy', retrieved 2026-08-29 - Pregnant women should follow the U.S. recommended daily allowances for pregnancy because their vitamin requirements may exceed those of non-pregnant women. Source: US FDA label for vitamin a (Pediatric Infuvite Multiple Vitamins), section 'pregnancy', retrieved 2026-08-29 - Animal reproduction studies have not been conducted with INFUVITE PEDIATRIC (multiple vitamins injection). Source: US FDA label for vitamin a (Pediatric Infuvite Multiple Vitamins), section 'pregnancy', retrieved 2026-08-29 BREASTFEEDING - INFUVITE PEDIATRIC has not been studied in nursing mothers. Source: US FDA label for vitamin a (Pediatric Infuvite Multiple Vitamins), section 'nursing mothers', retrieved 2026-08-29 - Lactating women may have vitamin requirements that exceed those of non-lactating women. Source: US FDA label for vitamin a (Pediatric Infuvite Multiple Vitamins), section 'nursing mothers', retrieved 2026-08-29 - Caution should be exercised when INFUVITE PEDIATRIC is administered to nursing mothers. Source: US FDA label for vitamin a (Pediatric Infuvite Multiple Vitamins), section 'nursing mothers', retrieved 2026-08-29 ``` --- Dawaa Reference is a reference for prescribers, not a medical device, and does not replace clinical judgement. [Privacy policy](/privacy)